A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age29-18
SponsorChildren's Hospital of Fudan University

About this trial

1\. To research the current situation of severe infection in children in China, and to investigate the incidence, prognosis and disease burden of severe infection in children in different regions of China. 2. Establish the risk prediction model and diagnosi model of severe infection in children, and verify the accuracy of the model in multi-center; 3. To study the effectiveness and safety of different treatments in real diagnosis and treatment, and to evaluate the efficacy of subgroups under different ages and high risk factors.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children between 0 and 18 years old.

Severe pneumonia and/or sepsis.

Disqualifiers

notifiable infectious diseases.

The researcher believes that he is not suitable to participate in other situations in this study.

Participants in other clinical trials in the same period.

Trial population

All children hospitalized in PICU of Children's Hospital of Fudan University from April 2021 to April 2025

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • Not applicable(Cohort study)

    Other intervention

    This is a prospective observational study and does not include interventions.

Treatment groups

5,000 Participants
are divided into 1 treatment group
Group A: Severe infection1 intervention

Trial outcomes

Primary outcomes

1

survival rate

The survival rate of children in 28 days after their discharged from PICU

Time frame
within 28 days after they discharged from PICU

Secondary outcomes

1

length of stay in PICU

Time from PICU admission to discharge

Time frame
within 28 days after they discharged from PICU

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.